Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anamorelin with systemic chemotherapy for metastatic urothelial carcinoma
jRCTs041210041Active, not recruiting
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of anamorelin in transitional cell carcinoma (TCC) (2 arms). Primary endpoint: Change from baseline in prealbumin at Week 12. Started Jul 2021; status: active, not recruiting.
02
Drugs
anamorelin
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on jRCTs041210041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041210041.